Castle Biosciences (CSTL) Earnings Analysis
Castle Biosciences (CSTL) next reports earnings on 2026-07-30, consensus EPS -0.44 USD. Last quarter (2026-02-26) it beat with EPS -0.08 USD vs -0.23 USD est (+65.2%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E -57.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CSTL next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -0.44 USD |
| Revenue estimate | 0.09B |
CSTL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.08 USD | -0.23 USD | +65.2% | Beat |
| 2025-11-03 | -0.02 USD | -0.34 USD | +94.1% | Beat |
| 2025-08-04 | 0.15 USD | -0.51 USD | +129.4% | Beat |
| 2025-05-05 | -0.2 USD | -0.08 USD | -150% | Miss |
| 2025-02-27 | 0.32 USD | -0.04 USD | +900% | Beat |
| 2024-11-04 | 0.08 USD | -0.06 USD | +233.3% | Beat |
| 2024-08-05 | 0.31 USD | -0.27 USD | +214.8% | Beat |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
CSTL valuation and analyst view
| Trailing P/E | -57.76 |
|---|---|
| Trailing EPS | -0.42932 USD |
| Price / book | 1.61 |
| Dividend yield | 0.00% |
| Market cap | 0.74B |
| Analyst consensus | Buy (11 buy / 0 hold / 0 sell) |
| Avg price target | 37.5 USD |
Related research pages
Frequently asked questions
When is Castle Biosciences (CSTL)'s next earnings date?
Castle Biosciences is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.44 USD and revenue estimate of 0.09B.
Did CSTL beat earnings last quarter?
In its 2026-02-26 report, CSTL posted EPS of -0.08 USD versus a -0.23 USD estimate — a beat of 65.2%.
What is CSTL's earnings track record?
Over the last 7 reported quarters with consensus data, CSTL beat estimates 6 times (86%).
What is CSTL's current P/E ratio and EPS?
CSTL trades at a trailing P/E of -57.76 on trailing EPS of -0.42932182408243835 USD.
What do analysts rate CSTL?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 37.5 USD.